The study aims to develop a long-acting formulation of one of the pharmaceutical company’s monoclonal antibodies, utilizing the PharmaShell system.
"Adding this project to our portfolio of collaborative ventures is truly gratifying, especially as we leverage our PharmaShell system in the field of monoclonal antibodies, an area we believe holds immense potential. It's, of course, equally thrilling for
The agreement regulates, among other things, details of what shall be investigated, clarification regarding patent rights, and a determined fee to
© Modular Finance, source